British Journal of Haematology

Malignant lymphoma and Schistosoma japonica infection
pp. 147-147(1)
Authors: Natori, Kazuhiko; Izumi, Haruka; Ishihara, Susumu; Fujimoto, Daisuke N. Y.; Kuraishi, Yasunobu

Myeloblastic transformation of chronic neutrophilic leukaemia
pp. 148-148(1)
Authors: Amato, D.; Memon, S.; Wang, C.

Advances in the understanding of mantle cell lymphoma
pp. 149-165(17)
Authors: Jares, Pedro; Campo, Elías

Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling
pp. 166-178(13)
Authors: Gleissner, B.; Küppers, R.; Siebert, R.; Glass, B.; Trümper, L.; Hiddemann, W.; Dreyling, M.

Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials
pp. 179-191(13)
Authors: Park, Hyun Jun; Neelapu, Sattva S.

TGF-β receptor kinase inhibitor LY2109761 reverses the anti-apoptotic effects of TGF-β1 in myelo-monocytic leukaemic cells co-cultured with stromal cells
pp. 192-201(10)
Authors: Xu, Yuanyuan; Tabe, Yoko; Jin, Linhua; Watt, Julie; McQueen, Teresa; Ohsaka, Akimichi; Andreeff, Michael; Konopleva, Marina

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome
pp. 202-215(14)
Authors: Rossi, Davide; Cerri, Michaela; Capello, Daniela; Deambrogi, Clara; Rossi, Francesca Maria; Zucchetto, Antonella; De Paoli, Lorenzo; Cresta, Stefania; Rasi, Silvia; Spina, Valeria; Franceschetti, Silvia; Lunghi, Monia; Vendramin, Chiara; Bomben, Riccardo; Ramponi, Antonio; Monga, Guido; Conconi, Annarita; Magnani, Corrado; Gattei, Valter; Gaidano, Gianluca

Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes
pp. 216-226(11)
Authors: Vega, Francisco; Cho-Vega, Jeong Hee; Lennon, Patrick A.; Luthra, Madan G.; Bailey, Jaime; Breeden, Megan; Jones, Dan; Medeiros, L. Jeffrey; Luthra, Rajyalakshmi

Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study
pp. 227-237(11)
Authors: Holowiecki, Jerzy; Krawczyk-Kulis, Malgorzata; Giebel, Sebastian; Jagoda, Krystyna; Stella-Holowiecka, Beata; Piatkowska-Jakubas, Beata; Paluszewska, Monika; Seferynska, Ilona; Lewandowski, Krzysztof; Kielbinski, Marek; Czyz, Anna; Balana-Nowak, Agnieszka; Król, Maria; Skotnicki, Aleksander B.; Jedrzejczak, Wieslaw W.; Warzocha, Krzysztof; Lange, Andrzej; Hellmann, Andrzej

Analysis of a large multi-generational family provides insight into the genetics of chronic lymphocytic leukemia
pp. 238-245(8)
Authors: Fuller, Stephen J.; Papaemmanuil, Elli; McKinnon, Leah; Webb, Emily; Sellick, Gabrielle S.; Dao-Ung, Lan-Phuong; Skarratt, Kristen K.; Crowther, Dalemari; Houlston, Richard S.; Wiley, James S.

Ocular adnexal lymphoma: no evidence for bacterial DNA associated with lymphoma pathogenesis
pp. 246-249(4)
Authors: Matthews, Julie M.; Moreno, Lilliana I.; Dennis, Jeremy; Byrne, Gerald E.; Ruiz, Phillip; Dubovy, Sander R.; Lossos, Izidore S.

Thromboelastography in children with coagulation factor deficiencies
pp. 250-256(7)
Authors: Chitlur, Meera; Warrier, Indira; Rajpurkar, Madhvi; Hollon, Wendy; Llanto, Lolita; Wiseman, Carol; Lusher, Jeanne M.

Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities
pp. 257-262(6)
Authors: Greystoke, Brigit; Bonanomi, Sonia; Carr, Trevor F.; Gharib, Maged; Khalid, Tasneem; Coussons, Mary; Jagani, Mamta; Naik, Paru; Rao, Kanchana; Goulden, Nicholas; Amrolia, Persis; Wynn, Robert F.; Veys, Paul A.

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria
pp. 263-272(10)
Authors: Schubert, Jörg; Hillmen, Peter; Röth, Alexander; Young, Neal S.; Elebute, Modupe O.; Szer, Jeffrey; Gianfaldoni, Giacomo; Socié, Gérard; Browne, Paul; Geller, Robert; Rother, Russell P.; Muus, Petra

The novel bispecific diabody αCD40/αCD28 strengthens leukaemic dendritic cell-induced T-cell reactivity
pp. 273-283(11)
Authors: Houtenbos, Ilse; Santegoets, Saskia; Westers, Theresia M.; Waisfisz, Quinten; Kipriyanov, Sergey; Denkers, Fedor; Scheper, Rik J.; de Gruijl, Tanja D.; Ossenkoppele, Gert J.; van de Loosdrecht, Arjan A.

Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia
pp. 284-292(9)
Authors: Holowiecki, Jerzy; Giebel, Sebastian; Wojnar, Jerzy; Krawczyk-Kulis, Malgorzata; Markiewicz, Miroslaw; Holowiecka-Goral, Aleksandra; Freund, Mathias; Casper, Jochen

Identification of erythropoietin-induced microRNAs in haematopoietic cells during erythroid differentiation
pp. 293-300(8)
Authors: Kosaka, Nobuyoshi; Sugiura, Keiichi; Yamamoto, Yusuke; Yoshioka, Yusuke; Miyazaki, Hiroshi; Komatsu, Norio; Ochiya, Takahiro; Kato, Takashi

The labile iron pool in human erythroid cells
pp. 301-307(7)
Authors: Prus, Eugenia; Fibach, Eitan

Von Willebrand disease and angiodysplasia responding to atorvastatin
pp. 308-309(2)
Authors: Sohal, Mamta; Laffan, Mike

Incidence and management of 82 cases of pregnancy-associated venous thromboembolism occurring at a single centre - comparison with Voke et al
pp. 309-311(3)
Authors: Lyall, Hamish; Myers, Bethan

Incidence and management of 82 cases of pregnancy-associated venous thromboembolism occurring at a single centre - Response to Lyall & Myers
pp. 311-312(2)
Authors: Voke, Jennifer; Pavord, Sue; Hunt, Beverley

Differential identification of PT-VWD from type 2B VWD and GP1BA nomenclature issues
pp. 312-314(3)
Author: Othman, M.

Differential identification of PT-VWD from type 2B VWD and GP1BA nomenclature issues response to Othman
pp. 314-315(2)
Authors: Favaloro, Emmanuel J.; Patterson, David; Denholm, Anna; Mead, Scott; Gilbert, Anne; Collins, Anne; Estell, Jane; George, Peter M.; Smith, Mark P.

Effect of subtotal splenectomy for management of hereditary pyropoikilocytosis
pp. 315-317(3)
Authors: Medejel, Nadia; Garçon, Loïc; Guitton, Corinne; Cynober, Thérèse; Bader-Meunier, Brigitte

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia
pp. 318-320(3)
Authors: Tholouli, Eleni; Liakopoulou, Effie; Greenfield, Hayley M.; Shaw, Bronwen E.; Tauro, Sudhir; Byrne, Jennifer L.; Dennis, Mike; Burthem, John; Lucas, Guy S.; Craddock, Charles; Russell, Nigel H.; Liu Yin, John A.

Viral microRNA profile in Epstein-Barr virus-associated peripheral T cell lymphoma
pp. 320-323(4)
Authors: Jun, Se Mo; Hong, Young Seon; Seo, Jung Seon; Ko, Yoon Ho; Yang, Chul Woo; Lee, Suk Kyeong

The deletion of SOX8 is not associated with ATR-16 in an HbH family from Brazil
pp. 324-326(3)
Authors: Bezerra, M. A. C. B.; Araujo, A. S.; Phylipsen, M.; Balak, D.; Kimura, E. M.; Oliveira, D. M.; Costa, F. F.; Sonati, M. F.; Harteveld, C. L.